Molina Healthcare, US60855R1005

Molina Healthcare stock holds steady after stronger 2026 guidance

Published on 08/22/2026 at 12:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Molina Healthcare stock has fresh numbers to digest after second-quarter 2026 EPS of $1.51 and full-year 2026 adjusted EPS guidance of at least $5.25.

Trading-Floor mit Händlern vor Bildschirmen mit Kursdiagrammen des Gesundheitssektors
Börsen-Editorial zeigt Molina Healthcare US60855R1005 anhand eines Trading-Floors mit Kursverläufen aus dem Gesundheitssektor, Illustration mit AI erstellt.

Molina Healthcare, Inc. (ISIN US60855R1005) enters August 22, 2026 with second-quarter 2026 adjusted EPS of $1.51, full-year 2026 adjusted EPS guidance of at least $5.25, and a market value that the latest quote snapshot places at $10.722 billion.

That same snapshot shows the shares trading in a $203.73 to $207.86 intraday band, while the 52-week range runs from $121.06 to $244.89. The stock is still far below the year high, but it trades well above the low reached over the past 12 months.

Second-quarter trend

Second-quarter 2026 revenue came in at $10.9 billion, down 4.8% year over year, while premium revenue totaled $10.2 billion and also fell 5.7% from a year earlier. Adjusted EPS of $1.51 beat the Zacks Consensus Estimate by 10.2%, even as top-line growth stayed negative.

The same report-based snapshot says management kept full-year 2026 premium revenue guidance at about $42 billion, which is down roughly 2% from 2025. It also lifted GAAP earnings guidance to at least $2.15 per diluted share from at least $1.90 and raised adjusted net income guidance to $268 million from $256 million.

Consensus still matters

Recent market-portal coverage points to a Hold consensus and a target price of $202.44, a level that sits below the latest intraday trading band. That gap gives investors a clean reference point for how the market is weighing the improved earnings outlook against a softer revenue picture.

The shares also trade with a 200-day moving average of $178.58, which keeps the chart above a longer-term trend marker even after the stock's pullback from the 52-week high. The 50-day average at $211.25 sits close to the latest trading range and helps define the near-term battleground.

What Molina sells

Molina Healthcare focuses on government-sponsored managed care, including Medicaid, Medicare, and Marketplace products for members who need coordinated medical and pharmacy coverage. That mix matters because enrollment, reimbursement, and medical cost trends can move results faster than headline revenue growth alone.

Price and setup

As of August 21, 2026, the latest quote snapshot showed Molina Healthcare at $203.73 to $207.86 during the session, with a market cap of $10.722 billion and volume of 93,427 shares. The 52-week range of $121.06 to $244.89 leaves the stock much closer to the top end than the bottom.

Market snapshot

Company: Molina Healthcare, Inc.
ISIN: US60855R1005
Ticker: MOH
Exchange: NYSE
Price (as of August 21, 2026, 4:00 p.m. ET): $203.73 - $207.86 USD
Market cap: $10.722 billion (as of August 21, 2026)
Sector / Industry: Health Care / Managed Health Care
Index membership: S&P 500

Disclaimer...

en | US60855R1005 | MOLINA HEALTHCARE | boerse | 69985571 | bgmi